Essential thrombocytosis
For patient information, click here
Template:DiseaseDisorder infobox
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis |
|
Risk calculators and risk factors for Essential thrombocytosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Essential thrombocythemia, primary thrombocythemia, inherited essential thrombocythemia, inherited Essential thrombocytosis, inherited essential thrombocythemia, inherited ET, congenital essential thrombocytosis, congenital essential thrombocythaemia, congenital essential thrombocythemia, congenital ET, hereditary essential thrombocytosis, hereditary essential thrombocythaemia, hereditary essential thrombocythemia, hereditary ET, familial essential thrombocythemia, familial essential thrombocytosis, familial essential thrombocythaemia, familial ET
Overview
Historical Perspective
Classification
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes
Differentiating Essential thrombocytosis from other Diseases
Natural History, Complications & Prognosis
Diagnosis
History & Symptoms | Physical Examination | Staging | Lab Tests | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Diagnostic criteria
Treatment
Medical Therapy | Special care related to pregnancy | Surgery | Primary Prevention | Secondary Prevention
Resources
- Cancerbackup Essential Thrombocytosis page
- CMPD Education Foundation
- MPD Foundation and Research Alliance - Register for a free newsletter
- Overview of Agrylin, the tradename for anagrelide hydrochloride